Anja Williams

647 total citations
13 papers, 454 citations indexed

About

Anja Williams is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anja Williams has authored 13 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anja Williams's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Anja Williams is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Anja Williams collaborates with scholars based in United Kingdom, Germany and United States. Anja Williams's co-authors include Wilfred A. Jefferies, W. L. Ford, Bent Rolstad, Niels Halama, Aram Mangasarian, Nicolas Hohmann, Dirk Eulberg, Meggy Suarez‐Carmona, Diana Beyer and Dirk Jäger and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Anja Williams

11 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Williams United Kingdom 7 292 91 85 80 48 13 454
Rachel E. Kohler Australia 5 588 2.0× 170 1.9× 98 1.2× 31 0.4× 52 1.1× 5 727
R K Lee United States 8 398 1.4× 88 1.0× 91 1.1× 102 1.3× 22 0.5× 10 640
Ellen Hilgenberg Germany 8 461 1.6× 107 1.2× 77 0.9× 48 0.6× 15 0.3× 11 650
Ayelet Snir Israel 8 306 1.0× 74 0.8× 47 0.6× 21 0.3× 21 0.4× 9 456
Stefanie Schmidt Germany 8 319 1.1× 65 0.7× 81 1.0× 62 0.8× 32 0.7× 13 519
Johannes Schwartzkopff Germany 12 229 0.8× 109 1.2× 106 1.2× 280 3.5× 30 0.6× 25 600
Kei Haniuda Japan 11 449 1.5× 70 0.8× 147 1.7× 51 0.6× 21 0.4× 22 607
David F. Carney United States 10 349 1.2× 31 0.3× 183 2.2× 40 0.5× 33 0.7× 13 530
J R Bender United States 8 330 1.1× 92 1.0× 103 1.2× 36 0.5× 129 2.7× 8 584
Boris P.-L. Lee Canada 11 187 0.6× 62 0.7× 98 1.2× 14 0.2× 23 0.5× 11 361

Countries citing papers authored by Anja Williams

Since Specialization
Citations

This map shows the geographic impact of Anja Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Williams more than expected).

Fields of papers citing papers by Anja Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Williams. The network helps show where Anja Williams may publish in the future.

Co-authorship network of co-authors of Anja Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Williams. A scholar is included among the top collaborators of Anja Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Williams. Anja Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Joshi, Kroopa, Antonella Cammarota, Rachel Woodford, et al.. (2025). Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials. JCO Precision Oncology. 9(9). e2400896–e2400896.
2.
Giordano, Antonio, Anja Williams, Binghe Xu, et al.. (2024). First-in-human phase 1/2a study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 + endocrine therapy (ET): Updated safety data in patients with HR+/HER2− mBC.. Journal of Clinical Oncology. 42(16_suppl). 3108–3108. 1 indexed citations
3.
Collins, Graham P., William Townsend, Swathi Namburi, et al.. (2023). A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL. Blood. 142(Supplement 1). 3093–3093. 3 indexed citations
4.
Whelan, Sarah, Jordan Ye, Ganesh Cherala, et al.. (2022). 777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies. Regular and Young Investigator Award Abstracts. A809–A809.
5.
Suarez‐Carmona, Meggy, Anja Williams, Nicolas Hohmann, et al.. (2021). Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects. Journal for ImmunoTherapy of Cancer. 9(10). e002505–e002505. 57 indexed citations
6.
7.
Halama, Niels, Anja Williams, Meggy Suarez‐Carmona, et al.. (2020). 1537P Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer. Annals of Oncology. 31. S944–S944. 8 indexed citations
8.
Michalarea, Vasiliki, Elisa Fontana, Alvaro Ingles Garces, et al.. (2019). Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review. Current Problems in Cancer. 43(5). 487–494. 7 indexed citations
9.
10.
Williams, Anja, et al.. (2013). PET-Negative Gastrointestinal Stromal Tumors. Case Reports in Oncology. 6(3). 508–513. 7 indexed citations
11.
Gourley, Charlie, Caroline O. Michie, Katherine E. Keating, et al.. (2011). Establishing a molecular taxonomy for epithelial ovarian cancer (EOC) from 363 formalin-fixed paraffin embedded (FFPE) specimens.. Journal of Clinical Oncology. 29(15_suppl). 5000–5000. 5 indexed citations
12.
Jefferies, Wilfred A., et al.. (1985). Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages.. The Journal of Experimental Medicine. 162(1). 117–127. 330 indexed citations
13.
Rolstad, Bent, Anja Williams, & W. L. Ford. (1974). THE ALLOANTIBODY RESPONSE TO A STRONG TRANSPLANTATION ANTIGEN (Ag-B). Transplantation. 17(4). 416–423. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel E. Kohler Breakdown of academic impact, for papers by R K Lee Breakdown of academic impact, for papers by Ellen Hilgenberg Breakdown of academic impact, for papers by Ayelet Snir Breakdown of academic impact, for papers by Stefanie Schmidt Breakdown of academic impact, for papers by Johannes Schwartzkopff Breakdown of academic impact, for papers by Kei Haniuda Breakdown of academic impact, for papers by David F. Carney Breakdown of academic impact, for papers by J R Bender Breakdown of academic impact, for papers by Boris P.-L. Lee
Rankless by CCL
2026